Study identifier:D589IC00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation for long-term use
Bronchial Asthma
-
No
-
All
1500
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2014 by AstraZeneca
AstraZeneca
-
The purpose of this study is to confirm the safety profile for long term treatment and maximize doses and the control status on bronchial asthma in daily clinical usage
Location
Location
Aichi, Japan, Japan
Location
Akita, Japan, Japan
Location
Aomori, Japan, Japan
Location
Chiba, Japan, Japan
Location
Ehime, Japan, Japan
Location
Fukui, Japan, Japan
Location
Fukuoka, Japan, Japan
Location
Fukushima, Japan, Japan
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.